Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance.
Open accessThe DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Abstract
The effect of graded, physiologic hyperinsulinemia (+5, +15, +30, +70, +200 microU/ml) on oxidative and nonoxidative pathways of glucose and FFA metabolism was examined in nine lean non-insulin dependent diabetic patients (NIDDM) and in eight age- and weight-matched control subjects. Glucose and FFA metabolism were assessed using stepwise insulin clamp in combination with indirect calorimetry and infusion of [3H]3-glucose/[14C]palmitate. The basal rate of hepatic glucose production (HGP) was higher in NIDDM than in control subjects, and suppression of HGP by insulin was impaired at all but the highest insulin concentration. Glucose disposal was reduced in the NIDD patients at the three highest plasma insulin concentrations, and this was accounted for by defects in both glucose oxidation and nonoxidative glucose metabolism. In NIDDs, suppression of plasma FFA by insulin was impaired at all five insulin steps. This was associated with impaired suppression by insulin of plasma FFA turnover, FFA oxidation (measured by [14C]palmitate) and nonoxidative FFA disposal (an estimate of reesterification of FFA). FFA oxidation and net lipid oxidation (measured by indirect calorimetry) correlated positively with the rate of HGP in the basal state and during the insulin clamp. In conclusion, our findings demonstrate that insulin resistance is a general characteristic of glucose and FFA metabolism in NIDDM, and involves both oxidative and nonoxidative pathways. The data also demonstrate that FFA/lipid and glucose metabolism are interrelated in NIDDM, and suggest that an increased rate of FFA/lipid oxidation may contribute to the impaired suppression of HGP and diminished stimulation of glucose oxidation by insulin in these patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Plasma insulin concentrations such as those observed during the present insulin/glucose or glucose infusion studies, are known to completely suppress hepatic glucose production (27); thus, under these conditions, total glucose uptake is equal to exogenous glucose infusion.”
From Differential effects of hyperinsulinemia and carbohydrate metabolism on sympathetic nerve activity and muscle blood flow in humans (1993) · cites this paper as [27]
In the citing paper
“Notably, insulin resistance is also associated with a decreased ability to suppress lipolysis in adipose tissue and altered fatty acid oxidation.50,51”
From The effects of sleep disruption on metabolism, hunger, and satiety, and the influence of psychosocial stress and exercise: A narrative review (2024) · cites this paper as [51]
In the citing paper
“In lean healthy individuals insulin stimulates glucose uptake into skeletal muscle in a dose-dependent manner, with a half-maximal effect (EC50) at a plasma insulin concentration ~60 μU/mL [21].”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [21]
In the citing paper
“Using the gold standard euglycemic hyperinsulinemic clamp technique to quantify insulin-stimulated glucose uptake, they demonstrated that both lean and obese T2DM subjects have marked decrease (>50%) in whole body glucose disposal during the insulin clamp.”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [21]
In the citing paper
“During the postabsorptive state, the plasma insulin concentration is low. Since the plasma insulin concentration is the principal factor that restrains lipolysis in adipocytes [21] and stimulates glucose uptake in skeletal muscle [21], during the fasting state, muscle glucose uptake is low and the plasma FFA concentration is elevated.”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [21]
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Self-citationRandle, P. J., Garland, P. B., Hales, C. N., & Newsholme, E. A. (1963) · The Lancet · doi:10.1016/s0140-6736(63)91500-9 · Cited by 5,093 · cited 2×
“More than 20 years ago Randle and co-workers introduced the concept of substrate competition, whereby enhanced availability and oxidation of FFA leads to an impairment in glucose oxidation (17).”
BackgroundImmunoassay of insulin with insulin-antibody precipitate
HALES, C., & RANDLE, P. (1963) · Biochemical Journal · doi:10.1042/bj0880137 · Cited by 2,638
The theoretical bases of indirect calorimetry: A review
Ferrannini, E. (1988) · Metabolism · doi:10.1016/0026-0495(88)90110-2 · Cited by 1,580
Self-citationRegulation of hepatic fatty acid oxidation and ketone body production
McGarry, J. D., & Foster, D. W. (1980) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.49.070180.002143 · Cited by 1,460 · cited 1×
“Since CPT I is inhibited by both insulin and malonyl-CoA, which is generated by condensation of acetyl-CoA (56), the insulin-mediated decline in FFA oxidation could have been due to a direct effect of the hormone on CPT I.”
BackgroundRelationship Between Carbohydrate and Lipid Metabolism and the Energy Balance of Heart Muscle
Neely, J. R., & Morgan, H. E. (1974) · Annual Review of Physiology · doi:10.1146/annurev.ph.36.030174.002213 · Cited by 1,261
DeFronzo, R. A., Gunnarsson, R., Björkman, O., Olsson, M., & Wahren, J. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111938 · Cited by 1,167 · cited 2×
“in insulin-mediated glucose metabolism affects both hepatic and peripheral tissues, primarily muscle (1-6).”
BackgroundSelf-citationEffect of fatty acids on glucose production and utilization in man.
Ferrannini, E., Barrett, E. J., Bevilacqua, S., & DeFronzo, R. A. (1983) · Journal of Clinical Investigation · doi:10.1172/jci111133 · Cited by 1,050
Self-citationRadioimmunological determination of human C-peptide in serum
Heding, L. G. (1975) · Diabetologia · doi:10.1007/bf01222104 · Cited by 830
Kolterman, O. G., Gray, R. S., Griffin, J., Burstein, P., Insel, J., Scarlett, J. A., & Olefsky, J. M. (1981) · Journal of Clinical Investigation · doi:10.1172/jci110350 · Cited by 629
Cited by
Items 201–300 of 812
Magkos, F., Fabbrini, E., Mohammed, B. S., Patterson, B. W., & Klein, S. (2010) · Obesity · doi:10.1038/oby.2010.90 · Cited by 95
“The low-dose insulin infusion rate was used to evaluate adipose tissue insulin sensitivity (suppression of lipolysis) and hepatic insulin sensitivity (suppression of glucose production) and the high-dose insulin infusion rate was used to evaluate skeletal muscle insulin sensitivity (stimulation of skeletal muscle gluc…”
MethodRossetti, L., Stenbit, A. E., Chen, W., Hu, M., Barzilai, N., Katz, E. B., & Charron, M. J. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119711 · Cited by 93
Metabolic fuel selection: general integration at the whole-body level
Randle, P. J. (1995) · Proceedings of the Nutrition Society · doi:10.1079/pns19950057 · Cited by 93
“Glucose oxidation is decreased in both untreated Type 1 and Type 2 diabetes; and glucose oxidation is resistant to stimulation by insulin in Type 2 diabetes, as are lipolysis and lipid oxidation (Groop et al. 1989).”
BackgroundFirouzjaei, A., Li, G.-C., Wang, N., Liu, W.-X., & Zhu, B.-M. (2016) · Nutrition & Diabetes · doi:10.1038/nutd.2016.16 · Cited by 91
Pendergrass, M., Bertoldo, A., Bonadonna, R., Nucci, G., Mandarino, L., Cobelli, C., & DeFronzo, R. A. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00617.2005 · Cited by 87
Self-citationPaolisso, G., Tagliamonte, M. R., Rizzo, M. R., Gualdiero, P., Saccomanno, F., Gambardella, A., Giugliano, D., D'Onofrio, F., & Howard, B. V. (1998) · Diabetologia · doi:10.1007/s001250051041 · Cited by 94
Diet-induced obesity impairs spermatogenesis: a potential role for autophagy
Yang, M., Yan, W., Yin, T., Zhang, Y., Li, J., & Yang, J. (2017) · Scientific Reports · doi:10.1038/srep43475 · Cited by 104
“Considering the close relationship between elevated serum free fatty acid level and obesity 41,42 , and to further decipher the effect of autophagy inhibition, sperm were separated and co-cultured with PA in vitro to mimic the conditions in vivo as described previously 38,39 .”
Miyazaki, Y., & DeFronzo, R. A. (2009) · Cardiovascular Diabetology · doi:10.1186/1475-2840-8-44 · Cited by 90
Self-citationHow to measure insulin action in vivo
Scheen, A. J., Paquot, N., Castillo, M. J., & Lefèbvre, P. J. (1994) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610100206 · Cited by 102
Contribution of muscle and liver to glucose-fatty acid cycle in humans
Saloranta, C., Koivisto, V., Widen, E., Falholt, K., DeFronzo, R. A., Harkonen, M., & Groop, L. (1993) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1993.264.4.e599 · Cited by 90
Self-citationAvogaro, A., Toffolo, G., Miola, M., Valerio, A., Tiengo, A., Cobelli, C., & Del Prato, S. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118754 · Cited by 87
“Furthermore, they are characterized by defective glucose oxidation (4, 6, 29, 30), an alteration inversely correlated with lipid oxidation (31).”
BackgroundModeling β -Cell Insulin Secretion - Implications for Closed-Loop Glucose Homeostasis
Steil, G. M., Rebrin, K., Janowski, R., Darwin, C. H., & Saad, M. F. (2003) · Diabetes Technology & Therapeutics · doi:10.1089/152091503322640999 · Cited by 109
Basu, R., Schwenk, W. F., & Rizza, R. A. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00549.2003 · Cited by 87
“This observation is consistent with previous studies that have shown that diabetes impairs suppression of lipolysis (24).”
ResultTreatment approach to type 2 diabetes: Past, present and future
Blaslov, K., Naranđa, F. S., Kruljac, I., & Renar, I. P. (2018) · World Journal of Diabetes · doi:10.4239/wjd.v9.i12.209 · Cited by 114
Mimura, K., Umeda, F., Hiramatsu, S., Taniguchi, S., Ono, Y., Nakashima, N., Kobayashi, K., Masakado, M., Yoshiyasu, S. A. K. O., & Nawata, H. (1994) · Diabetic Medicine · doi:10.1111/j.1464-5491.1994.tb00333.x · Cited by 87
Basal Insulin: Physiology, Pharmacology, and Clinical Implications
Niswender, K. D. (2011) · Postgraduate Medicine · doi:10.3810/pgm.2011.07.2300 · Cited by 103
Role of ethnicity in overweight and obese patients with nonalcoholic steatohepatitis
Lomonaco, R., Ortiz-Lopez, C., Orsak, B., Finch, J., Webb, A., Bril, F., Louden, C., Tio, F., & Cusi, K. (2011) · Hepatology · doi:10.1002/hep.24483 · Cited by 86
“Insulin is also a strong inhibitor of lipolysis, and a similar relationship exists in healthy subjects between the FPI concentration and fasting plasma FFA levels.(23) Thus, an index of adipocyte insulin resistance was calculated as the product of the fasting plasma FFA and insulin concentration (Adipo-IRi 1⁄4 FFA FPI…”
MethodThe Effect of Pioglitazone on the Liver
Gastaldelli, A., Miyazaki, Y., Mahankali, A., Berria, R., Pettiti, M., Buzzigoli, E., Ferrannini, E., & DeFronzo, R. A. (2006) · Diabetes Care · doi:10.2337/dc05-2445 · Cited by 86
“Experimental validation for the use of this index has been published (28,29).”
MethodSelf-citationPuhakainen, I. (1992) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.75.3.789 · Cited by 86
Non-insulin-dependent Diabetes Mellitus - A Collision between Thrifty Genes and an Affluent Society
Groop, L., & Tuomi, T. (1997) · Annals of Medicine · doi:10.3109/07853899708998742 · Cited by 112
Self-citationPathway of free fatty acid oxidation in human subjects. Implications for tracer studies.
Sidossis, L. S., Coggan, A. R., Gastaldelli, A., & Wolfe, R. R. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117652 · Cited by 86
“This implies that results from studies using tracer techniques alone or in combination with indirect calorimetry to estimate plasma and intracellular fatty acid oxidation (1-9), have likely underestimated the true value of plasma FFA oxidation.”
ResultMani, U. V., Mani, I., Biswas, M., & Kumar, S. N. (2011) · Journal of Dietary Supplements · doi:10.3109/19390211.2011.593615 · Cited by 85
“…that insulin resistance, hyperinsulinemia, impaired insulin secretion, reduced insulin-mediated glucose uptake/utilization (DeFronzo, 1997; Groop et al., 1989; Polonsky, Sturis, & Bell, 1996), and chronic hyperglycemia are the key factors responsible for causing multiple secondary…”
BackgroundHyperglycemia and Inhibition of Glycogen Synthase in Streptozotocin-treated Mice
Parker, G., Taylor, R., Jones, D., & McClain, D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312139200 · Cited by 85
Insulin dose response analysis of free fatty acid kinetics
Jensen, M. D., & Nielsen, S. (2006) · Metabolism · doi:10.1016/j.metabol.2006.08.022 · Cited by 88
Chen, M.-T., Kaufman, L. N., Spennetta, T., & Shrago, E. (1992) · Metabolism · doi:10.1016/0026-0495(92)90221-u · Cited by 83
Lipoproteins abnormalities in obese insulin-resistant dogs
Bailhache, E., Nguyen, P., Krempf, M., Siliart, B. S., Magot, T., & Ouguerram, K. (2003) · Metabolism · doi:10.1053/meta.2003.50110 · Cited by 83
Type 2 diabetes in South Asians: A pathophysiologic focus on the Asian-Indian epidemic
Bajaj, M., & Banerji, M. A. (2004) · Current Diabetes Reports · doi:10.1007/s11892-004-0026-4 · Cited by 96
“In type 2 diabetic individuals, the ability of insulin to inhibit lipolysis and reduce the plasma FFA concentration is markedly reduced [ 28 ].”
BackgroundKanat, M., DeFronzo, R. A., & Abdul-Ghani, M. A. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i12.1207 · Cited by 82
Self-citationAssociation of COVID-19 with Comorbidities: An Update
Chatterjee, S., Nalla, L. V., Sharma, M., Sharma, N., Singh, A. A., Malim, F. M., Ghatage, M., Mukarram, M., Pawar, A., Parihar, N., et al. (2023) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.2c00181 · Cited by 104
Diabetes and COVID-19; A Bidirectional Interplay
Kazakou, P., Lambadiari, V., Ikonomidis, I., Kountouri, A., Panagopoulos, G. N., Athanasopoulos, S., Korompoki, E., Kalomenidis, I., Dimopoulos, M. A., & Mitrakou, A. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.780663 · Cited by 98
“Experience from Severe Acute Respiratory Syndrome (SARS) and Middle East Respiratory Syndrome (MERS) suggests that inflammatory cells can affect the liver, impairing insulin-mediated glucose uptake, with hyperinsulinemia and hyperglycemia as a result (60, 61).”
Backgroundfor the RISC Study Group, Bonnet, F., Disse, E., Laville, M., Mari, A., Højlund, K., Anderwald, C. H., Piatti, P., & Balkau, B. (2012) · Diabetologia · doi:10.1007/s00125-012-2701-3 · Cited by 87
“The graded increase in NEFA concentration across alcohol consumption categories observed in the present study is consistent with both the increased clearance of insulin and reduced basal insulin secretion rate, observed in parallel with increasing alcohol intake, as insulin inhibits lipolysis and NEFA release in healt…”
BackgroundAntihypertensive treatment with beta-blockers and the spectrum of glycaemic control
Sarafidis, P. A., & Bakris, G. L. (2006) · QJM · doi:10.1093/qjmed/hcl059 · Cited by 84
Lipid-dependent control of hepatic glycogen stores in healthy humans
Stingl, H., Krššák, M., Krebs, M., Bischof, M. G., Nowotny, P., Fürnsinn, C., Shulman, G. I., Waldhäusl, W., & Roden, M. (2001) · Diabetologia · doi:10.1007/s001250051579 · Cited by 85
Measuring and estimating insulin resistance in clinical and research settings
Matsuda, M. (2010) · Nutrition, Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2009.07.007 · Cited by 80
Assessment of insulin action and glucose effectiveness in diabetic and nondiabetic humans.
Alzaid, A. A., Dinneen, S. F., Turk, D. J., Caumo, A., Cobelli, C., & Rizza, R. A. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117599 · Cited by 80
“When submaximal insulin concentrations are used, this method has shown repeatedly that people with NIDDM have both hepatic and extrahepatic insulin resistance (3-7).”
BackgroundMethodInsulin Resistance the Link between T2DM and CVD: Basic Mechanisms and Clinical Implications
Abdul‐Ghani, M. A., Jayyousi, A., DeFronzo, R. A., Asaad, N., & Suwaidi, J. M. S. A. (2017) · Current Vascular Pharmacology · doi:10.2174/1570161115666171010115119 · Cited by 82
Self-citationHeated hand vein blood is satisfactory for measurements during free fatty acid kinetic studies
Jensen, M. D., & Heiling, V. J. (1991) · Metabolism · doi:10.1016/0026-0495(91)90152-m · Cited by 77
Luzi, L., Perseghin, G., Brendel, M. D., Terruzzi, I., Battezzati, A., Eckhard, M., Brandhorst, D., Brandhorst, H., Friemann, S., Socci, C., et al. (2001) · Diabetes · doi:10.2337/diabetes.50.2.277 · Cited by 78
“In the last decade, we (7–10) and others (11,12) found that protein and lipid metabolism had greater sensitivity to acutely infused insulin than did glucose metabolism, both in diabetes and uremia.”
BackgroundArslanian, S. A., Kim, J. Y., Nasr, A., Bacha, F. F., Tfayli, H. M., Lee, S., & Toledo, F. G. S. (2017) · Pediatric Diabetes · doi:10.1111/pedi.12562 · Cited by 82
“rate was corrected for insulin concentrations (ie, Rd/steady-state insulin concentration).(27,28) Even though the clamp steady-state glucose concentrations were different between youth and adults, in the nor-”
BackgroundAmeliorative Effects of Stabilized Rice Bran on Type 2 Diabetes Patients
Cheng, H.-H., Huang, H., Chen, Y.-Y., Huang, C.-L., Chang, C.-J., Chen, H.-L., & Lai, M.-H. (2009) · Annals of Nutrition and Metabolism · doi:10.1159/000265850 · Cited by 82
Physiological and Molecular Determinants of Insulin Action in the Baboon
Chavez, A. O., Lopez-Alvarenga, J. C., Tejero, M. E., Triplitt, C., Bastarrachea, R. A., Sriwijitkamol, A., Tantiwong, P., Voruganti, V. S., Musi, N., Comuzzie, A. G., et al. (2008) · Diabetes · doi:10.2337/db07-0790 · Cited by 75
“Previous work has addressed conditions and markers associated with insulin resistance such as atherosclerosis, dyslipidemia, and obesity in this model (4,12, 27,28).”
Self-citationJobori, H. A., Daniele, G., Adams, J. M., Cersósimo, E., Triplitt, C. L., DeFronzo, R. A., & Abdul‐Ghani, M. A. (2017) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12881 · Cited by 86
Self-citationThe Effect of Rosiglitazone on the Liver: Decreased Gluconeogenesis in Patients with Type 2 Diabetes
Gastaldelli, A., Miyazaki, Y., Pettiti, M., Santini, E., Ciociaro, D., DeFronzo, R. A., & Ferrannini, E. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1159 · Cited by 75
Self-citationAssessment of hepatic insulin action in obese type 2 diabetic patients
Staehr, P., Hother-Nielsen, O., Levin, K., Holst, J. J., & Beck-Nielsen, H. (2001) · Diabetes · doi:10.2337/diabetes.50.6.1363 · Cited by 74
Managing insulin resistance: the forgotten pathophysiological component of type 2 diabetes
Abdul-Ghani, M. A., Maffei, P., & DeFronzo, R. A. (2024) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(24)00127-x · Cited by 89
Self-citationMethods for quantifying adipose tissue insulin resistance in overweight/obese humans
ter Horst, K. W., van Galen, K. A., Gilijamse, P. W., Hartstra, A. V., de Groot, P. F., van der Valk, F. M., Ackermans, M. T., Nieuwdorp, M., Romijn, J. A., & Serlie, M. J. M. (2017) · International Journal of Obesity · doi:10.1038/ijo.2017.110 · Cited by 88
Insulin resistance and antidiabetic drugs
Bailey, C. J. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00191-4 · Cited by 81
Jung, U. J., Baek, N., Chung, H., Bang, M., Jeong, T., Lee, K., Kang, Y.-J., Lee, M., Kim, H., Yeo, J., et al. (2007) · Clinical Nutrition · doi:10.1016/j.clnu.2007.09.009 · Cited by 78
Triacylglycerol turnover in isolated working hearts of acutely diabetic rats
Saddik, M., & Lopaschuk, G. D. (1994) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y94-157 · Cited by 74
Rendell, M., Hulthén, U. L., Törnquist, C., Groop, L., & Mattiasson, I. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.2.7260 · Cited by 74
“However, the previous studies evaluating the Randle cycle (35) were, in general, carried out in subjects with noninsulin-dependent diabetes (36, 37 ) and in more obese individuals than included in the present study (mean BMI, 30 ‐33 kg/m22 compared with 28”
ResultSelf-citationJazet, I. M., Schaart, G., Gastaldelli, A., Ferrannini, E., Hesselink, M. K. C., Schrauwen, P., Romijn, J. A., Maassen, J. A., Pijl, H., Ouwens, D. M., et al. (2007) · Diabetologia · doi:10.1007/s00125-007-0862-2 · Cited by 86
“Experimental validation for the use of this index has been published [26, 27].”
MethodSelf-citationGlucokinase and candidate genes for Type 2 (non-insulin-dependent) diabetes mellitus
Randle, P. J. (1993) · Diabetologia · doi:10.1007/bf00400227 · Cited by 81
“The two major pathogenic components are a subnormal plasma insulin concentration, consistently demonstrable after controlling for obesity and blood glucose concentration [65]; and insulin resistance in respect of insulin-induced hypoglycaemia [66], muscle glycogen synthesis [67] and other aspects of glucose and fatty…”
BackgroundAdipose Insulin Resistance in Obese Adolescents Across the Spectrum of Glucose Tolerance
Hershkop, K., Besor, O., Santoro, N., Pierpont, B., Caprio, S., & Weiss, R. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1376 · Cited by 72
“The Adipose Insulin Resistance index (Adipose IR) was calculated as the product of fasting insulin and FFA concentrations (22).”
MethodCarpentier, A., Patterson, B. W., Uffelman, K. D., Giacca, A., Vranic, M., Cattral, M. S., & Lewis, G. F. (2001) · Diabetes · doi:10.2337/diabetes.50.6.1402 · Cited by 71
“Individuals with insulin resistance and diabetes are hyperinsulinemic and are resistant to the antilipolytic effect of insulin in peripheral tissues (15,16).”
BackgroundHepatic glucose production in insulin‐resistant states
Ferrannini, E., & Groop, L. C. (1989) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610050806 · Cited by 76
Self-citationPlasma levels of free fatty acids correlate with type 2 diabetes mellitus
Spiller, S., Blüher, M., & Hoffmann, R. (2018) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13449 · Cited by 83
Cincotta, A. H., & MEIER, A. H. (1995) · Metabolism · doi:10.1016/0026-0495(95)90041-1 · Cited by 85
Bak, J. F., Møller, N., Schmitz, O., Saaek, A., & Pedersen, O. B. (1992) · Diabetologia · doi:10.1007/bf00429100 · Cited by 80
“In Type 2 diabetic patients both oxidative and non-oxidative glucose metabolism are impaired during hyperinsulinaemia [23, 24 ].”
BackgroundShort Term Voluntary Overfeeding Disrupts Brain Insulin Control of Adipose Tissue Lipolysis
Scherer, T., Lindtner, C., Zielinski, E., O'Hare, J., Filatova, N., & Buettner, C. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.307348 · Cited by 70
Brouwers, B., Schrauwen-Hinderling, V. B., Jelenik, T., Gemmink, A., Sparks, L. M., Havekes, B., Bruls, Y., Dahlmans, D., Roden, M., Hesselink, M. K. C., et al. (2018) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00266.2017 · Cited by 69
“Suppression of plasma free fatty acids as a measurement of adipose tissue insulin sensitivity is indirect; however, and may depend on the concentration of insulin used (16), which in our study was lower compared with the study by Meex et al.”
ResultAnfosso, F. J., Chomiki, N., Alessi, M., Vague, P., & Juhan-Vague, I. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116445 · Cited by 68
Effect of Pioglitazone on the Metabolic and Hormonal Response to a Mixed Meal in Type II Diabetes
Gastaldelli, A., Casolaro, A., Pettiti, M., Nannipieri, M., Ciociaro, D., Frascerra, S., Buzzigoli, E., Baldi, S., Mari, A., & Ferrannini, E. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100034 · Cited by 68
Self-citationNonequilibrium thermodynamics and energy efficiency in weight loss diets
Feinman, R. D., & Fine, E. J. (2007) · Theoretical Biology and Medical Modelling · doi:10.1186/1742-4682-4-27 · Cited by 67
“Wolfe and coworkers [76-78] have emphasized the extent to which glucose controls fatty acid metabolism rather than the other way around as originally suggested in the Randle cycle [79,80].”
Franssila-Kallunki, A., & Groop, P. (1992) · Diabetologia · doi:10.1007/bf00401426 · Cited by 74
“Under conditions of metabolic deterioration the increase in lipid oxidation may be necessary to compensate for the reduction in glucose oxidation [17].”
BackgroundGougeon, R., Pencharz, P. B., & Sigal, R. J. (1997) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/65.3.861 · Cited by 73
Sokooti, S., Flores-Guerrero, J. L., Heerspink, H. J. L., Connelly, M. A., Bakker, S. J. L., & Dullaart, R. P. F. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-021-01348-w · Cited by 71
Christiansen, M. P., Linfoot, P. A., Neese, R. A., & Hellerstein, M. K. (2000) · Diabetes · doi:10.2337/diabetes.49.10.1691 · Cited by 66
“Individuals with type 2 diabetes require higher insulin levels to suppress lipolysis (41).”
BackgroundJourdan, T., Demizieux, L., Gresti, J., Djaouti, L., Gaba, L., Vergès, B. L., & Degrace, P. (2011) · Hepatology · doi:10.1002/hep.24733 · Cited by 68
“Such conditions are encountered in vivo in the fasting state and, particularly, in type II diabetes that is associated with excessive rise in plasma free FA.44 In line with this, direct evidence for an improvement of FA catabolism by CB1R blockade in the steatotic liver is provided by the present findings showing an i…”
BackgroundGlucose-Fatty Acid Interaction in Skeletal Muscle and Adipose Tissue in Insulin Resistance
Cahová, M., Vavřínková, H., & Kazdová, L. (2007) · Physiological Research · doi:10.33549/physiolres.930882 · Cited by 71
Pereira, M. J., Skrtic, S., Katsogiannos, P., Abrahamsson, N., Sidibeh, C. O., Dahgam, S., Månsson, M., Risérus, U., Kullberg, J., & Eriksson, J. W. (2016) · Metabolism · doi:10.1016/j.metabol.2016.09.008 · Cited by 71
Turpeinen, A. K., Takala, T. O., Nuutila, P., Axelin, T., Luotolahti, M., Haaparanta, M., Bergman, J., Hämäläinen, H., Iida, H., Mäki, M., et al. (1999) · Diabetes · doi:10.2337/diabetes.48.6.1245 · Cited by 65
Landstedt-Hallin, L., Adamson, U., & Lins, P.-E. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.9.6002 · Cited by 65
“The peripheral insulin levels in our patients (70–75 mU/L) were probably not high enough to completely suppress hepatic glucose production (55), which has to be taken into consideration when interpreting our results.”
BackgroundRen, T., He, J., Jiang, H., Zu, L., Pu, S., Guo, X., & Xu, G. (2006) · Journal of Molecular Endocrinology · doi:10.1677/jme.1.02061 · Cited by 64
“The biguanide, metformin, is widely used for the treatment of NIDDM.”
BackgroundInfluentialObesity in the pathogenesis of type 2 diabetes
Day, C., & Bailey, C. J. (2011) · The British Journal of Diabetes · doi:10.1177/1474651411407418 · Cited by 86
Storgaard, H., Jensen, C. B., Vaag, A. A., Vølund, A., & Madsbad, S. (2003) · Metabolism · doi:10.1016/s0026-0495(03)00102-1 · Cited by 64
Pioglitazone Improves Left Ventricular Diastolic Function in Subjects With Diabetes
Clarke, G. D., Solis-Herrera, C., Molina-Wilkins, M., Martinez, S., Merovci, A., Cersosimo, E., Chilton, R. J., Iozzo, P., Gastaldelli, A., Abdul-Ghani, M., et al. (2017) · Diabetes Care · doi:10.2337/dc17-0078 · Cited by 63
“Peripheral tissues, including skeletal (7) and cardiac (8,9) muscle, liver (10), and adipose tissue (11), are resistant to insulin in T2D.”
BackgroundSelf-citationAbdul‐Ghani, M. A., Molina‐Carrión, M., Jani, R., Jenkinson, C. P., & DeFronzo, R. A. (2008) · Acta Diabetologica · doi:10.1007/s00592-008-0033-z · Cited by 70
“Experimental validation of this index previously has been published [11].”
BackgroundMethodInfluentialSelf-citationCombining GLP ‐1 receptor agonists with insulin: therapeutic rationales and clinical findings
Holst, J. J., & Vilsbøll, T. (2013) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2012.01628.x · Cited by 63
“Adipocyte insulin resistance, resulting in increased lipolysis and circulating free fatty acid levels, also plays a role in T2DM pathophysiology [30,31].”
BackgroundObesity, insulin resistance, and its link to non-insulin-dependent diabetes mellitus
Walker, M. (1995) · Metabolism · doi:10.1016/0026-0495(95)90314-3 · Cited by 63
Rogers, E. M., Banks, N. F., & Jenkins, N. D. M. (2024) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3667 · Cited by 62
“50,51 Thus, a few studies have also determined the effects of experimental sleep restriction on indicators of postprandial lipid metabolism in response to either glucose tolerance tests or hyperinsulinemic ‐ euglycemic clamps.”
BackgroundChen, M., Zhu, B., Chen, D., Hu, X., Xu, X., Shen, W., Hu, C., Li, J., & Qu, S. (2021) · Endocrine Practice · doi:10.1016/j.eprac.2021.04.004 · Cited by 71
Wlazlo, N., van Greevenbroek, M. M. J., Ferreira, I., Jansen, E. H. J. M., Feskens, E. J. M., Kallen, C., Schalkwijk, C. G., Bravenboer, B., & Stehouwer, C. D. A. (2014) · Acta Diabetologica · doi:10.1007/s00592-014-0646-3 · Cited by 63
“fasting) concentrations (10–20 mU/L) [33, 34].”
Kooner, J. S., Baliga, R. R., Wilding, J., Crook, D., Packard, C. J., Banks, L. M., Peart, S., Aitman, T. J., & Scott, J. (1998) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.18.7.1021 · Cited by 61
Guerra, S., Mocciaro, G., & Gastaldelli, A. (2021) · European Journal of Clinical Investigation · doi:10.1111/eci.13695 · Cited by 65
Lakshmi, B. S., Sujatha, S., Anand, S., Sangeetha, K. N., Narayanan, R. B., KATIYAR, C., Kanaujia, A., Duggar, R., Singh, Y. P., SRINIVAS, K., et al. (2009) · Journal of Diabetes · doi:10.1111/j.1753-0407.2009.00022.x · Cited by 68
“Treatment of T2DM is complicated by several factors inherent to the disease process, typically insulin resistance, hyperinsulinemia, impaired insulin secretion, and reduced insulin-mediated glucose uptake and utilization.(1) Therapy using insulin and other agents (e.”
BackgroundScherer, T., & Buettner, C. (2011) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-011-9190-4 · Cited by 60
“WAT dysfunction is observed in lipodystrophic [9], obese and DM2 patients [10–12] and results in elevated circulating FFAs.”
BackgroundChondronikola, M., Harris, L. L. S., & Klein, S. (2016) · Journal of Internal Medicine · doi:10.1111/joim.12527 · Cited by 61
Katsuki, A., Sumida, Y., Urakawa, H., Gabazza, E. C., Murashima, S., Morioka, K., Kitagawa, N., Tanaka, T., Araki-Sasaki, R., Hori, Y., et al. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020486 · Cited by 60
“Peripheral insulin resistance is generally associated with decreased ability of insulin to suppress adipose tissue lipolysis (17).”
BackgroundBoon, H., Blaak, E. E., Saris, W. H. M., KEIZER, H. A., Wagenmakers, A. J. M., & van Loon, L. J. C. (2006) · Diabetologia · doi:10.1007/s00125-006-0482-2 · Cited by 65
“As a consequence, plasma insulin levels do not compensate for the adipose tissue insulin resistance present in type 2 diabetes [37–40] and fail to inhibit adipose tissue lipolysis.”
BackgroundSundsten, T., Eberhardson, M., Göransson, M., & Bergsten, P. (2006) · Proteome Science · doi:10.1186/1477-5956-4-22 · Cited by 64
“Background Elevated fasting glucose levels and extended postprandial hyperglycemia are cardinal traits of individuals with type 2 diabetes mellitus (T2DM) [1-3].”
BackgroundEffect of IGF-I on FFA and glucose metabolism in control and type 2 diabetic subjects
Pratipanawatr, T., Pratipanawatr, W., Rosen, C., Berria, R., Bajaj, M., Cusi, K., Mandarino, L., Kashyap, S., Belfort, R., & DeFronzo, R. A. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00335.2001 · Cited by 59
“Plasma-tritiated glucose radioactivity was determined on barium hydroxide and zinc sulfate-precipitated plasma samples, as previously described (18).”
BackgroundMethodInfluentialSelf-citationAdipose tissue as an endocrine organ: implications of its distribution on free fatty acid metabolism
Jensen, M. D. (2006) · European Heart Journal Supplements · doi:10.1093/eurheartj/sul003 · Cited by 74
“Increased hepatic FFA delivery induces increased gluconeogenesis in the liver.(21) This has been proposed to occur via several mechanisms relating to increased availability of biochemical substrates, such as ATP (energy source for gluconeogenesis and inhibitor of glycolysis at the level of phosphofructokinase), acetyl…”
BackgroundThe Relationship Between β-Cell Function and Glycated Hemoglobin
Kanat, M., Winnier, D., Norton, L., Arar, N., Jenkinson, C., DeFronzo, R. A., & Abdul-Ghani, M. A. (2011) · Diabetes Care · doi:10.2337/dc10-1352 · Cited by 58
Self-citationPaolisso, G., Gambardella, A., Marrazzo, G., Verza, M., Teasuro, P., Varricchio, M., & D’Onofrio, F. (1992) · American Heart Journal · doi:10.1016/0002-8703(92)90753-i · Cited by 58
Liver Fat Content and Hepatic Insulin Sensitivity in Overweight Patients With Type 1 Diabetes
Llauradó, G., Sevastianova, K., Sädevirta, S., Hakkarainen, A., Lundbom, N., Orho-Melander, M., Groop, P.-H., Forsblom, C., & Yki-Järvinen, H. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3050 · Cited by 56
Mechanisms of metformin inhibiting lipolytic response to isoproterenol in primary rat adipocytes
Zhang, T., He, J., Xu, C. B., Zu, L., Jiang, H., Pu, S., Guo, X., & Xu, G. (2008) · Journal of Molecular Endocrinology · doi:10.1677/jme-08-0130 · Cited by 64
“Obesity and type 2 diabetes (diabetes mellitus) are associated with elevated levels of plasma free fatty acids (FFA), which restrict glucose utilization and induce insulin resistance (Groop et al. 1989, Bergman & Ader 2000).”
BackgroundIozzo, P., Pratipanawatr, T., Pijl, H., Vogt, C., Kumar, V., Pipek, R., Matsuda, M., Mandarino, L. J., Cusi, K. J., & DeFronzo, R. A. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.280.5.e712 · Cited by 57
“Our failure to observe an increase in muscle glycogen concentration is consistent with previous observations in humans that elevations in the plasma insulin concentration of ,30 mU/ml do not stimulate nonoxidative glucose disposal (14).”
ResultSelf-citationBegum, N., & Ragolia, L. (1998) · Metabolism · doi:10.1016/s0026-0495(98)90193-7 · Cited by 56
Andrikopoulos, S., & Proietto, J. (1995) · Diabetologia · doi:10.1007/bf00400598 · Cited by 56
Richardson, D. K., Schneider, J. L., Fourcaudot, M. J., Rodriguez, L. M., Arya, R., Dyer, T. D., Almasy, L. A., Blangero, J., Stern, M. P., DeFronzo, R. A., et al. (2006) · Diabetologia · doi:10.1007/s00125-006-0384-3 · Cited by 61
Self-citation
Metadata
- Authors
- Groop, L. C., Bonadonna, R. C., DelPrato, S., Ratheiser, K., Zyck, K., Ferrannini, E., & DeFronzo, R. A.
- Affiliations
- University of Helsinki (FI)
- Venue
- Journal of Clinical Investigation
- Published
- 1989-07-01
- Volume
- 84
- Issue
- 1
- Pages
- 205-213
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC303971
- OpenAlex
- W1981456793
- Cited by
- 812
- References
- 61
- Citations by year
- 2026: 8 · 2025: 11 · 2024: 28 · 2023: 15 · 2022: 27 · 2021: 30 · 2020: 19 · 2019: 17 · 2018: 25 · 2017: 32 · 2016: 26 · 2015: 22 · 2014: 22 · 2013: 26 · 2012: 26
- FWCI
- 16.26
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- CINECA IRIS Institutial research information system (University of Pisa) (submittedVersion)
- Funders
- National Institutes of Health (AM 24 092)
- Fogarty International Center (F05-TWO-3451)
- National Center for Research Resources (RR 125)
- Ministero dell'Istruzione e del Merito
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
- Keywords
- type 2 diabetes, insulin resistance, glucose metabolism, free fatty acid metabolism, hepatic glucose production, glucose oxidation, nonoxidative glucose metabolism, fatty acid oxidation, fatty acid re-esterification, hyperinsulinemia, insulin clamp, lipid oxidation
- MeSH terms
- Blood Glucose, C-Peptide, Diabetes Mellitus, Type 2, Fatty Acids, Nonesterified, Female, Glucose, Humans, Insulin, Insulin Resistance, Liver, Male, Middle Aged, Oxidation-Reduction, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.